The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Molecular profiles of small cell bladder and prostate cancer and comparisons with small cell lung cancer.
 
Nancy Ann Dawson
Honoraria - Amgen; Astellas Pharma; AstraZeneca; Bayer; Eisai; Exelixis; Genentech/Roche; Janssen Biotech; Merck; Novartis; Pfizer; Sanofi
Consulting or Advisory Role - Janssen Scientific Affairs
Speakers' Bureau - Amgen; Astellas Pharma; AstraZeneca; Bayer; Dendreon; Eisai; Exelixis; Genentech/Roche; Janssen Biotech; Merck; Novartis; Pfizer; Sanofi
Research Funding - Acceleron Pharma (Inst); Bayer (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Pfizer (Inst); Roche/Genentech (Inst); Tokai Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Caris Life Sciences
 
Daniel M. Geynisman
Consulting or Advisory Role - Exelixis; Novartis; Pfizer
Research Funding - Genentech (Inst); Merck (Inst); Millennium (Inst); Pfizer (Inst)
 
Earle Frederick Burgess
Stock and Other Ownership Interests - Becton Dickinson; Calithera Biosciences; Exelixis; Gilead Sciences; Ignyta; Johnson & Johnson; McKesson; Medtronic
Consulting or Advisory Role - Bayer; Janssen; Pfizer; Roche/Genentech
Speakers' Bureau - Exelixis; Roche/Genentech
Research Funding - Astellas Pharma; Pfizer
Travel, Accommodations, Expenses - Exelixis; Pfizer; Roche/Genentech
 
Bradley G. Somer
No Relationships to Disclose
 
David Arguello
Employment - Caris Life Sciences
Stock and Other Ownership Interests - Caris Life Sciences
 
Ralph J. Hauke
Stock and Other Ownership Interests - Aethlon
Honoraria - Best Doctors, Inc
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Pharmacyclics (Inst); SOTIO (Inst); US Oncology (Inst)
Patents, Royalties, Other Intellectual Property - Patent pending on an immunotherapeutic
Other Relationship - ABIM Subspecialty Board
 
Daniel A. Vaena
Consulting or Advisory Role - AstraZeneca; Exelixis
Research Funding - Acerta Pharma (Inst); Argos Therapeutics (Inst); AstraZeneca (Inst); BioClin Therapeutics (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Peloton Therapeutics (Inst); Roche/Genentech (Inst); Tekmira (Inst); TRACON Pharma (Inst)
 
Derek Raghavan
Consulting or Advisory Role - Caris Life Sciences (Inst); Gerson Lehrman Group
 
Elisabeth I. Heath
Honoraria - Bayer; Dendreon; Sanofi
Consulting or Advisory Role - Agensys
Speakers' Bureau - Sanofi
Research Funding - Agensys (Inst); Celgene (Inst); Celldex (Inst); Dendreon (Inst); Genentech/Roche (Inst); Inovio Pharmaceuticals (Inst); Millennium (Inst); Seagen (Inst); Tokai Pharmaceuticals (Inst)